Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis

CONCLUSIONS: Although the studies' heterogeneity was high, in a prescription dose ranging from 70 Gy to 250 Gy to the tumor apex, 106Ru brachytherapy seems to be successful in local control of uveal melanoma. The efficacy of 106Ru in controlling uveal melanomas decreased with the increase in tumor thickness. However, these outcomes should be verified in randomized comparative studies.PMID:34122577 | PMC:PMC8170514 | DOI:10.5114/jcb.2021.106191
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research